Biotech News
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
ir.minervaneurosciences.com2026-05-06 15:16 EST
BURLINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief